AIMD: Ainos, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6.15
Enterprise Value ($M) 13.27
Book Value ($M) 18.02
Book Value / Share 1.30
Price / Book 0.34
NCAV ($M) -7.70
NCAV / Share -0.56
Price / NCAV -0.80

Profitability (mra)
Return on Invested Capital (ROIC) -0.53
Return on Assets (ROA) -0.48
Return on Equity (ROE) -0.58

Liquidity (mrq)
Quick Ratio 1.33
Current Ratio 1.37

Balance Sheet (mrq) ($M)
Current Assets 5.65
Assets 31.37
Liabilities 13.35
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
08-21 13D Taiwan Carbon Nano Technology Corp 40.23
08-20 13D/A Ainos Inc 17.97 -16.41
05-08 13D Advanced Semiconductor Engineering Inc 27.40
05-06 13D/A Amarillo Biosciences Inc 63.36 76.37

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-08 10-K U.S. Securities and Exchange Commission Washington, D.C. 20549 FORM 10-K
2024-02-15 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 8,540 26,674 32.02
2024-11-21 66,714 128,810 51.79
2024-11-20 33,095 59,132 55.97
2024-11-19 39,935 84,599 47.21
2024-11-18 13,778 26,345 52.30

(click for more detail)

Similar Companies
ADTX – Aditxt, Inc. ADVM – Adverum Biotechnologies, Inc.
AGEN – Agenus Inc. AKAN – Akanda Corp.
AKBA – Akebia Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.